Andexanet Alfa for Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: Does a Specific Reversal Agent Justify Its Cost?

Saved in:
Bibliographic Details
Published inNeurology Vol. 97; no. 21; p. 971
Main Authors Patel, Nikhil, Morris, Nicholas A
Format Journal Article
LanguageEnglish
Published United States 23.11.2021
Subjects
Cerebral Hemorrhage - chemically induced
Factor Xa
Factor Xa Inhibitors - adverse effects
Humans
Recombinant Proteins
Rivaroxaban
Online AccessGet more information

Cover

More Information
ISSN:1526-632X
DOI:10.1212/WNL.0000000000012857